Skip to main navigation Skip to search Skip to main content

SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway–Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)

  • Charu Aggarwal
  • , Mary W. Redman
  • , Primo N. Lara
  • , Hossein Borghaei
  • , Philip Hoffman
  • , Jeffrey D. Bradley
  • , Alfred J. Newman
  • , Marvin J. Feldman
  • , Katherine Minichiello
  • , Jieling Miao
  • , Philip C. Mack
  • , Vassiliki A. Papadimitrakopoulou
  • , Roy S. Herbst
  • , Karen Kelly
  • , David R. Gandara

Research output: Contribution to journal › Article › peer-review

83   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway–Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Keyphrases